image

Cell Dissociation Market Report Scope & Overview:

The Cell Dissociation Market size was estimated USD 352.83 million in 2023 and is expected to reach USD 975.82 million by 2031 at a CAGR of 13.56% during the forecast period of 2024-2031. 

The cell dissociation process is known to use proteolytic enzymes to remove the adhering cell from the surface or substrate. Cell dissociation cushions feature collagenolytic and proteolytic properties that detach cell lines and tissues from the plastic or glass surfaces of the containers, increasing isolation efficacy with high cell practicality.Century Therapeutics and Bristol Myers Squibb announced a research collaboration and license agreement for up to four iPSC-derived initiatives for solid tumors and hematologic malignancies in September 2022. Furthermore, launching novel items provides attractive chances within the anticipated time. LevitasBio, for example, in November 2022, Optimized Tissue Dissociation Reagents release. Tissue dissociation kits from the company are specifically built for the LeviCell processes, enabling for end-to-end handling of a wide range of human and model tissue types such as heart, tumor, brain, liver, lung, and kidney.

Cell Dissociation Market Revenue Analysis

Get more information on Cell Dissociation Market - Request Free Sample Report

MARKET DYNAMICS

DRIVERS

  • Rise in recombinant therapeutics sourced from mammalian cells

The share of recombinant medicines in the biopharmaceutical industry has increased significantly. More than 300 recombinant products had been launched as of June 2022, showing a significant transition toward mammalian-based treatments, which will account for over 67% of therapeutics in 2023. Cell culture products, such as cell dissociation, are essential in the development of mammalian-based recombinant therapies, accelerating business growth.

RESTRAIN 

  • Cell-based research is expensive.

Isolation and purification of cell organelles need costly products, and automated/semi-automated benchtop tools are more expensive than older approaches. Despite the tremendous benefits provided by automated instruments, the high costs associated with these instruments may limit product adoption, thereby restraining market growth.

 OPPORTUNITY 

  • Non-enzymatic tissue dissociation advancement

Companies operating in the market are introducing novel and improved items to compete and create more income. To separate cells from primary tissues, most researchers in R&D institutes and biotechnology companies have relied on standard enzymatic dissociation tools. Although these classic enzymatic dissociation products have advantages, such as improved dissociation while conducting research, they can also be harmful and kill living cells. To address this issue and differentiate their product offers, some companies are launching non-enzymatic, non-cytotoxic solutions. Because of this benefit, the demand for non-enzymatic dissociation products is expanding among a variety of end users.

CHALLENGES

  • Dissociated cell culture has some limitations.

The main challenge of dissociated cultures is their low cell count in comparison to immortalized cell lines. This makes doing biochemical studies needing a large starting material volume challenging. Furthermore, most initial cell cultures are not homogenous, which makes cell dissociation investigations difficult. Neuronal cultures are frequently combinations of glia and neurons that respond to distinct neurotransmitters, making it challenging to identify an individual population of cells.

IMPACT OF RUSSIAN UKRAINE WAR

In response to the ongoing war in Ukraine, Danaher Corp. has banned the export of products to Russia, with the exception of products used for diagnosing and treating patients, as well as the production of vaccines and treatments. The Company incurred a $43 million pretax charge in the first quarter of 2022, principally attributable to the impairment of accounts receivable and inventories, as well as accruals for contractual commitments connected to Russian operations.

KEY SEGMENTS

By Product

  • Enzymatic Dissociation

    • Trypsin

    • Collagenase

    • Elastase

    • Papain

    • Hyaluronidase

    • DNase

    • Others

  • Non-enzymatic dissociation

  • Instruments & Accessories

In 2023, Enzymatic Dissociation segment is expected to held the highest market share of 48.0% during the forecast period due to enzymatic dissociation is a technique that uses enzymes to breakdown the cut-up tissue fragments, freeing the cells from the tissue. Several types of enzymes are utilized in the dissociation process, and they can also be used in tandem. Enzymatic dissociations in general give a more effective and efficient approach of isolating mononuclear cells from the spinal cord and brain.

By Type

  • Tissue Dissociation

  • Cell Detachment

In 2023, the Tissue Dissociation segment is expected to dominate the market growth of 56.6% during the forecast period due to Factors such as biopharmaceutical and pharmaceutical firms' increased attention on the development of monoclonal antibodies and therapeutic customisation are expected to boost the expansion of this segment.

By End User

  • Pharmaceutical And Biotechnology Companies

  • Research & Academic Institutes

In 2023, Pharmaceutical and Biotechnology Companies segment is expected to dominate the market growth of 71.7% during the forecast period to due to the cell dissociation enzymes are widely used in medications. Collagenase and trypsin are important enzymes in the preservation of solid tissues and adherent cells for culture and research. Furthermore, cell tissue disaggregation and dissociation represent the beginning of a wide range of research End Users, including cancer treatments, cell growth, and vaccine manufacture.

REGIONAL ANALYSES

North America held a significant market share of around 37.3% in 2023 owing to the region's large proportion can be linked to the government's increased investment initiatives, the increased prevalence of chronic diseases like as cancer, as well as the existence of high-quality clinical and laboratory research infrastructure in the region. According to the Globocan study, roughly 2,281,659 new cancer cases were documented in the United States in 2022, with around 712,391 deaths. Thus, the increased frequency of chronic and infectious diseases, combined with a greater emphasis on cell-based treatments, is extending the market's potential prospects.

Asia-Pacific is witness to expand fastest CAGR rate during the forecast period due to the increasing demand for innovative medicines. Increasing government R&D investments and rapid infrastructure development are two other significant drivers driving regional market expansion. Furthermore, some area businesses are receiving financing to investigate treatments for chronic diseases such as cancer. For example, in June 2022, Immuneel Therapeutics received a budget of USD 15 million for developing affordable cell and gene therapy for cancer patients in India.

Cell-Dissociation-Market-By-Region

REGIONAL COVERAGE

North America

  • US

  • Canada

  • Mexico

Europe

  • Eastern Europe

    • Poland

    • Romania

    • Hungary

    • Turkey

    • Rest of Eastern Europe

  • Western Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Netherlands

    • Switzerland

    • Austria

    • Rest of Western Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Vietnam

  • Singapore

  • Australia

  • Rest of Asia Pacific

Middle East & Africa

  • Middle East

    • UAE

    • Egypt

    • Saudi Arabia

    • Qatar

    • Rest of Middle East

  • Africa

    • Nigeria

    • South Africa

    • Rest of Africa

Latin America

  • Brazil

  • Argentina

  • Colombia

  • Rest of Latin America

Key Players

The major key players are Thermo Fisher Scientific, Danaher Corp., Merck KGaA, Sartorius AG, BD, PAN-Biotech, HiMedia Laboratories,STEMCELL Technologies, F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., S2 Genomics, Inc., Miltenyi Biotec and Others.

Danaher Corp-Company Financial Analysis

Company Landscape Analysis

RECENT DEVELOPMENT

In March 2023, Agilent Technologies Inc. has purchased the revolutionary electron capture dissociation (ECD) technology known as the ExD cell, a tiny equipment for mass spectrometers that allows biological researchers to manufacture biotherapeutic chemicals more quickly to treat disease. This is performed by breaking the chemical bonds of complex biomolecules more fully and precisely, allowing for the extraction of more thorough, exact, and detailed structural information from them.  

In 2021, Danaher (Cytiva) collaborated with Diamyd Medical, who chose Cytiva's FlexFactory technology for producing precision medicine type 1 diabetes vaccines.

In 2021, Danaher (Cytiva) partnered with the Government of Telangana (India) to expand the biopharma business in India by opening new labs.

Cell Dissociation Market Report Scope:
Report Attributes Details
Market Size in 2023  US$ 352.83 Million
Market Size by 2031  US$ 975.82 Million
CAGR   CAGR of 13.56% From 2024 to 2031
Base Year 2023
Forecast Period  2024-2031
Historical Data  2020-2022
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product (Enzymatic Dissociation, Non-enzymatic dissociation, Instruments & Accessories)
• By Type (Tissue Dissociation, Cell Detachment)
• By End User (Pharmaceutical and Biotechnology Companies, Research & Academic Institutes)
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)
Company Profiles Thermo Fisher Scientific, Danaher Corp., Merck KGaA, Sartorius AG, BD, PAN-Biotech, HiMedia Laboratories,STEMCELL Technologies, F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., S2 Genomics, Inc., Miltenyi Biotec
Key Drivers • Rise in recombinant therapeutics sourced from mammalian cells
Market Challenges • Dissociated cell culture has some limitations.

 

Frequently Asked Questions

Ans: Cell Dissociation Market is anticipated to expand by 13.56% from 2024 to 2031.

Ans: Cell Dissociation Market size was valued at USD 352.83 million in 2023.

Ans:   USD 975.82 million is expected to grow by 2031.

Ans: Huge range of products available to help researchers, pharmaceutical companies, and clinicians in their efforts to study, manipulate, and utilize cells.

Ans: Limitations of Dissociated cell culture.

TABLE OF CONTENTS

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Industry Flowchart

3. Research Methodology

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

5. Impact Analysis

5.1 Impact of Russia-Ukraine Crisis

5.2 Impact of Economic Slowdown on Major Countries

5.2.1 Introduction

5.2.2 United States

5.2.3 Canada

5.2.4 Germany

5.2.5 France

5.2.6 UK

5.2.7 China

5.2.8 Japan

5.2.9 South Korea

5.2.10 India

6. Value Chain Analysis

7. Porter’s 5 Forces Model

8. Pest Analysis

9. Cell Dissociation Market Segmentation, By Product

9.1 Introduction

    1. Trend Analysis

9.3Enzymatic Dissociation

9.3.1 Trypsin

9.3.2 Collagenase

9.3.3 Elastase

9.3.4 Papain

9.3.5 Hyaluronidase

9.3.6 DNase

9.3.7 Others

9.4 Non-enzymatic dissociation

9.5 Types & Accessories

10. Cell Dissociation Market Segmentation, By Type

    1. Introduction

10.2 Trend Analysis

10.3 Tissue Dissociation

10.4 Cell Detachment

11. Cell Dissociation Market Segmentation, By End user

11.1 Introduction

    1. Trend Analysis

11.3 Pharmaceutical And Biotechnology Companies

11.4 Research & Academic Institutes

12. Regional Analysis

12.1 Introduction

12.2 North America

12.2.1 Trend Analysis

12.2.2 North America Cell Dissociation Market by Country

12.2.3 North America Cell Dissociation Market By Product

12.2.4 North America Cell Dissociation Market By Type

12.2.5 North America Cell Dissociation Market By End user

12.2.6 USA

12.2.6.1 USA Cell Dissociation Market By Product

12.2.6.2 USA Cell Dissociation Market By Type

12.2.6.3 USA Cell Dissociation Market By End user

12.2.7 Canada

12.2.7.1 Canada Cell Dissociation Market By Product

12.2.7.2 Canada Cell Dissociation Market By Type

12.2.7.3 Canada Cell Dissociation Market By End user

12.2.8 Mexico

12.2.8.1 Mexico Cell Dissociation Market By Product

12.2.8.2 Mexico Cell Dissociation Market By Type

12.2.8.3 Mexico Cell Dissociation Market By End user

12.3 Europe

12.3.1 Trend Analysis

12.3.2 Eastern Europe

12.3.2.1 Eastern Europe Cell Dissociation Market by Country

12.3.2.2 Eastern Europe Cell Dissociation Market By Product

12.3.2.3 Eastern Europe Cell Dissociation Market By Type

12.3.2.4 Eastern Europe Cell Dissociation Market By End user

12.3.2.5 Poland

12.3.2.5.1 Poland Cell Dissociation Market By Product

12.3.2.5.2 Poland Cell Dissociation Market By Type

12.3.2.5.3 Poland Cell Dissociation Market By End user

12.3.2.6 Romania

12.3.2.6.1 Romania Cell Dissociation Market By Product

12.3.2.6.2 Romania Cell Dissociation Market By Type

12.3.2.6.4 Romania Cell Dissociation Market By End user

12.3.2.7 Hungary

12.3.2.7.1 Hungary Cell Dissociation Market By Product

12.3.2.7.2 Hungary Cell Dissociation Market By Type

12.3.2.7.3 Hungary Cell Dissociation Market By End user

12.3.2.8 Turkey

12.3.2.8.1 Turkey Cell Dissociation Market By Product

12.3.2.8.2 Turkey Cell Dissociation Market By Type

12.3.2.8.3 Turkey Cell Dissociation Market By End user

12.3.2.9 Rest of Eastern Europe

12.3.2.9.1 Rest of Eastern Europe Cell Dissociation Market By Product

12.3.2.9.2 Rest of Eastern Europe Cell Dissociation Market By Type

12.3.2.9.3 Rest of Eastern Europe Cell Dissociation Market By End user

12.3.3 Western Europe

12.3.3.1 Western Europe Cell Dissociation Market by Country

12.3.3.2 Western Europe Cell Dissociation Market By Product

12.3.3.3 Western Europe Cell Dissociation Market By Type

12.3.3.4 Western Europe Cell Dissociation Market By End user

12.3.3.5 Germany

12.3.3.5.1 Germany Cell Dissociation Market By Product

12.3.3.5.2 Germany Cell Dissociation Market By Type

12.3.3.5.3 Germany Cell Dissociation Market By End user

12.3.3.6 France

12.3.3.6.1 France Cell Dissociation Market By Product

12.3.3.6.2 France Cell Dissociation Market By Type

12.3.3.6.3 France Cell Dissociation Market By End user

12.3.3.7 UK

12.3.3.7.1 UK Cell Dissociation Market By Product

12.3.3.7.2 UK Cell Dissociation Market By Type

12.3.3.7.3 UK Cell Dissociation Market By End user

12.3.3.8 Italy

12.3.3.8.1 Italy Cell Dissociation Market By Product

12.3.3.8.2 Italy Cell Dissociation Market By Type

12.3.3.8.3 Italy Cell Dissociation Market By End user

12.3.3.9 Spain

12.3.3.9.1 Spain Cell Dissociation Market By Product

12.3.3.9.2 Spain Cell Dissociation Market By Type

12.3.3.9.3 Spain Cell Dissociation Market By End user

12.3.3.10 Netherlands

12.3.3.10.1 Netherlands Cell Dissociation Market By Product

12.3.3.10.2 Netherlands Cell Dissociation Market By Type

12.3.3.10.3 Netherlands Cell Dissociation Market By End user

12.3.3.11 Switzerland

12.3.3.11.1 Switzerland Cell Dissociation Market By Product

12.3.3.11.2 Switzerland Cell Dissociation Market By Type

12.3.3.11.3 Switzerland Cell Dissociation Market By End user

12.3.3.1.12 Austria

12.3.3.12.1 Austria Cell Dissociation Market By Product

12.3.3.12.2 Austria Cell Dissociation Market By Type

12.3.3.12.3 Austria Cell Dissociation Market By End user

12.3.3.13 Rest of Western Europe

12.3.3.13.1 Rest of Western Europe Cell Dissociation Market By Product

12.3.3.13.2 Rest of Western Europe Cell Dissociation Market By Type

12.3.3.13.3 Rest of Western Europe Cell Dissociation Market By End user

12.4 Asia-Pacific

12.4.1 Trend Analysis

12.4.2 Asia-Pacific Cell Dissociation Market by Country

12.4.3 Asia-Pacific Cell Dissociation Market By Product

12.4.4 Asia-Pacific Cell Dissociation Market By Type

12.4.5 Asia-Pacific Cell Dissociation Market By End user

12.4.6 China

12.4.6.1 China Cell Dissociation Market By Product

12.4.6.2 China Cell Dissociation Market By Type

12.4.6.3 China Cell Dissociation Market By End user

12.4.7 India

12.4.7.1 India Cell Dissociation Market By Product

12.4.7.2 India Cell Dissociation Market By Type

12.4.7.3 India Cell Dissociation Market By End user

12.4.8 Japan

12.4.8.1 Japan Cell Dissociation Market By Product

12.4.8.2 Japan Cell Dissociation Market By Type

12.4.8.3 Japan Cell Dissociation Market By End user

12.4.9 South Korea

12.4.9.1 South Korea Cell Dissociation Market By Product

12.4.9.2 South Korea Cell Dissociation Market By Type

12.4.9.3 South Korea Cell Dissociation Market By End user

12.4.10 Vietnam

12.4.10.1 Vietnam Cell Dissociation Market By Product

12.4.10.2 Vietnam Cell Dissociation Market By Type

12.4.10.3 Vietnam Cell Dissociation Market By End user

12.4.11 Singapore

12.4.11.1 Singapore Cell Dissociation Market By Product

12.4.11.2 Singapore Cell Dissociation Market By Type

12.4.11.3 Singapore Cell Dissociation Market By End user

12.4.12 Australia

12.4.12.1 Australia Cell Dissociation Market By Product

12.4.12.2 Australia Cell Dissociation Market By Type

12.4.12.3 Australia Cell Dissociation Market By End user

12.4.13 Rest of Asia-Pacific

12.4.13.1 Rest of Asia-Pacific Cell Dissociation Market By Product

12.4.13.2 Rest of Asia-Pacific Cell Dissociation Market By Type

12.4.13.3 Rest of Asia-Pacific Cell Dissociation Market By End user

12.5 Middle East & Africa

12.5.1 Trend Analysis

12.5.2 Middle East

12.5.2.1 Middle East Cell Dissociation Market by Country

12.5.2.2 Middle East Cell Dissociation Market By Product

12.5.2.3 Middle East Cell Dissociation Market By Type

12.5.2.4 Middle East Cell Dissociation Market By End user

12.5.2.5 UAE

12.5.2.5.1 UAE Cell Dissociation Market By Product

12.5.2.5.2 UAE Cell Dissociation Market By Type

12.5.2.5.3 UAE Cell Dissociation Market By End user

12.5.2.6 Egypt

12.5.2.6.1 Egypt Cell Dissociation Market By Product

12.5.2.6.2 Egypt Cell Dissociation Market By Type

12.5.2.6.3 Egypt Cell Dissociation Market By End user

12.5.2.7 Saudi Arabia

12.5.2.7.1 Saudi Arabia Cell Dissociation Market By Product

12.5.2.7.2 Saudi Arabia Cell Dissociation Market By Type

12.5.2.7.3 Saudi Arabia Cell Dissociation Market By End user

12.5.2.8 Qatar

12.5.2.8.1 Qatar Cell Dissociation Market By Product

12.5.2.8.2 Qatar Cell Dissociation Market By Type

12.5.2.8.3 Qatar Cell Dissociation Market By End user

12.5.2.9 Rest of Middle East

12.5.2.9.1 Rest of Middle East Cell Dissociation Market By Product

12.5.2.9.2 Rest of Middle East Cell Dissociation Market By Type

12.5.2.9.3 Rest of Middle East Cell Dissociation Market By End user

12.5.3 Africa

12.5.3.1 Africa Cell Dissociation Market by Country

12.5.3.2 Africa Cell Dissociation Market By Product

12.5.3.3 Africa Cell Dissociation Market By Type

12.5.3.4 Africa Cell Dissociation Market By End user

12.5.3.5 Nigeria

12.5.3.5.1 Nigeria Cell Dissociation Market By Product

12.5.3.5.2 Nigeria Cell Dissociation Market By Type

12.5.3.5.3 Nigeria Cell Dissociation Market By End user

12.5.3.6 South Africa

12.5.3.6.1 South Africa Cell Dissociation Market By Product

12.5.3.6.2 South Africa Cell Dissociation Market By Type

12.5.3.6.3 South Africa Cell Dissociation Market By End user

12.5.3.7 Rest of Africa

12.5.3.7.1 Rest of Africa Cell Dissociation Market By Product

12.5.3.7.2 Rest of Africa Cell Dissociation Market By Type

12.5.3.7.3 Rest of Africa Cell Dissociation Market By End user

12.6 Latin America

12.6.1 Trend Analysis

12.6.2 Latin America Cell Dissociation Market by country

12.6.3 Latin America Cell Dissociation Market By Product

12.6.4 Latin America Cell Dissociation Market By Type

12.6.5 Latin America Cell Dissociation Market By End user

12.6.6 Brazil

12.6.6.1 Brazil Cell Dissociation Market By Product

12.6.6.2 Brazil Cell Dissociation Market By Type

12.6.6.3 Brazil Cell Dissociation Market By End user

12.6.7 Argentina

12.6.7.1 Argentina Cell Dissociation Market By Product

12.6.7.2 Argentina Cell Dissociation Market By Type

12.6.7.3 Argentina Cell Dissociation Market By End user

12.6.8 Colombia

12.6.8.1 Colombia Cell Dissociation Market By Product

12.6.8.2 Colombia Cell Dissociation Market By Type

12.6.8.3 Colombia Cell Dissociation Market By End user

12.6.9 Rest of Latin America

12.6.9.1 Rest of Latin America Cell Dissociation Market By Product

12.6.9.2 Rest of Latin America Cell Dissociation Market By Type

12.6.9.3 Rest of Latin America Cell Dissociation Market By End user

13. Company Profiles

13.1 Thermo Fisher Scientific

13.1.1 Company Overview

13.1.2 Financial

13.1.3 Product/ Services Offered

13.1.4 SWOT Analysis

13.1.5 The SNS View

13.2 Danaher Corp.

13.2.1 Company Overview

13.2.2 Financial

13.2.3 Product / Services Offered

13.2.4 SWOT Analysis

13.2.5 The SNS View

13.3 Vitrolife

13.3.1 Company Overview

13.3.2 Financial

13.3.3 Product / Services Offered

13.3.4 SWOT Analysis

13.3.5 The SNS View

13.4 Merck KGaA

13.4.1 Company Overview

13.4.2 Financial

13.4.3 Product / Services Offered

13.4.4 SWOT Analysis

13.4.5 The SNS View

13.5 Sartorius AG

13.5.1 Company Overview

13.5.2 Financial

13.5.3 Product/ Services Offered

13.5.4 SWOT Analysis

13.5.5 The SNS View

13.6 PAN-Biotec

13.6.1 Company Overview

13.6.2 Financial

13.6.3 Product/ Services Offered

13.6.4 SWOT Analysis

13.6.5 The SNS View

13.7 HiMedia Laboratories

13.7.1 Company Overview

13.7.2 Financial

13.7.3 Product/ Services Offered

13.7.4 SWOT Analysis

13.7.5 The SNS View

13.8 STEMCELL Technologies

13.8.1 Company Overview

13.8.2 Financial

13.8.3 Product/ Services Offered

13.8.4 SWOT Analysis

13.8.5 The SNS View

13.9 F. Hoffmann-La Roche Ltd.

13.9.1 Company Overview

13.9.2 Financial

13.9.3 Product/ Services Offered

13.9.4 SWOT Analysis

13.9.5 The SNS View

13.10 Agilent Technologies Inc.

13.10.1 Company Overview

13.10.2 Financial

13.10.3 Product/ Services Offered

13.10.4 SWOT Analysis

13.10.5 The SNS View

14. Competitive Landscape

14.1 Competitive Benchmarking

14.2 Market Share Analysis

14.3 Recent Developments

14.3.1 Industry News

14.3.2 Company News

14.3.3 Mergers & Acquisitions

15. Use Case and Best Practices

16. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone